Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?
LaVoie Health Science Blog
JULY 1, 2020
Sharp gains and losses in share prices, together with significant changes in share ownership mean that few companies, particularly those in the life science sector, are immune from the potential disruptions of shareholder activism. The COVID-19 pandemic has led to unprecedented volatility in equity markets.
Let's personalize your content